Day One Biopharmaceuticals, Inc.
DelistedCIK 1845337fmd_0P0P9Q79CXSVK6ZTNAX6CBRV72Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 25 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | 0 | 0 | 131 | 158 |
| Net interest income | (2) | (0) | 0 | 5 | – | – | – |
| Realized investment gains (losses) | – | – | – | – | 0 | – | – |
| Research and development | 14 | 9 | 44 | 86 | 131 | 228 | 148 |
| Total operating expenses | 15 | 14 | 73 | 147 | 206 | 348 | 286 |
| Operating income | (15) | (14) | (73) | (147) | (206) | (217) | (128) |
| Other non-operating income (expense) | (0) | (0) | (0) | 5 | 17 | 129 | 18 |
| Income tax expense | – | – | – | 0 | 0 | 7 | (2) |
| Net income | (13) | (41) | (72,754) | (142,181) | (188,917) | (95,496) | (107,322) |
| Net income to common shareholders | – | – | (71) | (142) | (189) | – | – |